Kelly Financial Services LLC Navidea Biopharmaceuticals, Inc. Transaction History

Kelly Financial Services LLC

  • $258 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jul 17, 2024
SELL
$0.03 - $0.09 $1 - $4
-50 Closed
0 $0
Q3 2021

Jul 17, 2024
SELL
$1.53 - $1.85 $64 - $77
-42 Reduced 45.65%
50 $88,000
Q2 2021

Jul 17, 2024
BUY
$1.55 - $2.15 $65 - $90
42 Added 84.0%
92 $50,000
Q2 2019

Jul 17, 2024
BUY
$0.62 - $3.6 $31 - $180
50 New
50 $32,000

Others Institutions Holding NAVB

# of Institutions
3
Shares Held
10.4K
Call Options Held
0
Put Options Held
0
View Full List

About NAVIDEA BIOPHARMACEUTICALS, INC.

NAVB Quotes by TradingView
  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email